210 related articles for article (PubMed ID: 18473741)
1. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.
Zhang JY; Nawoschik S; Kowal D; Smith D; Spangler T; Ochalski R; Schechter L; Dunlop J
Eur J Pharmacol; 2003 Jul; 472(1-2):33-8. PubMed ID: 12860470
[TBL] [Abstract][Full Text] [Related]
3. Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor.
Wood M; Chaubey M; Atkinson P; Thomas DR
Eur J Pharmacol; 2000 May; 396(1):1-8. PubMed ID: 10822046
[TBL] [Abstract][Full Text] [Related]
4. Techniques: promiscuous Galpha proteins in basic research and drug discovery.
Kostenis E; Waelbroeck M; Milligan G
Trends Pharmacol Sci; 2005 Nov; 26(11):595-602. PubMed ID: 16183138
[TBL] [Abstract][Full Text] [Related]
5. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
[TBL] [Abstract][Full Text] [Related]
6. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
Newman-Tancredi A; Cussac D; Marini L; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
[TBL] [Abstract][Full Text] [Related]
7. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
Wurch T; Colpaert FC; Pauwels PJ
Neuropharmacology; 2003 Jun; 44(7):873-81. PubMed ID: 12726819
[TBL] [Abstract][Full Text] [Related]
8. ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors.
Riccioni T; Bordi F; Minetti P; Spadoni G; Yun HM; Im BH; Tarzia G; Rhim H; Borsini F
Eur J Pharmacol; 2011 Jul; 661(1-3):8-14. PubMed ID: 21549693
[TBL] [Abstract][Full Text] [Related]
9. Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.
Boess FG; Monsma FJ; Carolo C; Meyer V; Rudler A; Zwingelstein C; Sleight AJ
Neuropharmacology; 1997; 36(4-5):713-20. PubMed ID: 9225298
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacology of adrenergic alpha(2C) receptors coupled to Ca(2+) signaling through different Galpha proteins.
Kurko D; Bekes Z; Gere A; Baki A; Boros A; Kolok S; Bugovics G; Nagy J; Szombathelyi Z; Ignácz-Szendrei G
Neurochem Int; 2009 Dec; 55(7):467-75. PubMed ID: 19426776
[TBL] [Abstract][Full Text] [Related]
12. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
13. Latest advances towards the discovery of 5-HT(7) receptor ligands.
Pittala V; Pittala D
Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
[TBL] [Abstract][Full Text] [Related]
14. S 14506: novel receptor coupling at 5-HT(1A) receptors.
Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Molderings GJ; Frölich D; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
[TBL] [Abstract][Full Text] [Related]
18. Introduction of the 5-HT3B subunit alters the functional properties of 5-HT3 receptors native to neuroblastoma cells.
Stewart A; Davies PA; Kirkness EF; Safa P; Hales TG
Neuropharmacology; 2003 Feb; 44(2):214-23. PubMed ID: 12623220
[TBL] [Abstract][Full Text] [Related]
19. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
20. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
Yun HM; Rhim H
Toxicol In Vitro; 2011 Dec; 25(8):2035-40. PubMed ID: 21864673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
